Clinical Trial Update: Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating posaconazole and benznidazole for chronic Chagas disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Drugs mentioned

• Benznidazole (benznidazole)
• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Chagas Disease | Phase 2 | Status: COMPLETED